Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 72
Filtrar
1.
Ir Med J ; 111(10): 843, 2018 12 06.
Artículo en Inglés | MEDLINE | ID: mdl-30560639

RESUMEN

Introduction Perinatal lumbar discectomy for lumbar disc herniation or cauda equina syndrome is a rare clinical scenario. This case series outlines the surgical management of this clinical scenario at a national tertiary referral centre over a 10-year period Methods A retrospective review of all females who underwent discectomy / decompression for lumbar disc herniation or cauda equina syndrome in the perinatal period at a national tertiary referral centre for spine surgery over a 10-year period between January 2008 to December 2017. Results 6 cases required surgical intervention. All patients were successfully managed with surgical decompressive procedures and recovered well in the postoperative period without complication. Conclusions The principles of management remain the same in the pregnant and non-pregnant populations, although treatment options are complicated by the desire to avoid risk to the developing foetus. Surgical intervention is safe to both mother and baby and if performed promptly is associated with an excellent functional outcome.


Asunto(s)
Síndrome de Cauda Equina/cirugía , Desplazamiento del Disco Intervertebral/cirugía , Vértebras Lumbares , Complicaciones del Embarazo , Adulto , Descompresión Quirúrgica/métodos , Femenino , Humanos , Desplazamiento del Disco Intervertebral/diagnóstico por imagen , Imagen por Resonancia Magnética , Embarazo , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento
2.
J Appl Microbiol ; 122(3): 796-808, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27981713

RESUMEN

AIMS: Saliva has been previously used as an inoculum for in vitro oral biofilm studies. However, the microbial community profile of saliva is markedly different from hard- and soft-tissue-associated oral biofilms. Here, we investigated the changes in the biofilm architecture and microbial diversity of in vitro oral biofilms developed from saliva, tongue or plaque-derived inocula under different salivary shear forces. METHODS AND RESULTS: Four inoculum types (saliva, bacteria harvested from the tongue, toothbrush and curette-harvested plaque) were collected and pooled. Biofilms (n ≥ 15) were grown for 20 h in cell-free human saliva flowing at three different shear forces. Stained biofilms were imaged using a confocal laser scanning microscope. Biomass, thickness and roughness were determined by image analysis and bacterial community composition analysed using Ion Torrent. All developed biofilms showed a significant reduction in observed diversity compared with their respective original inoculum. Shear force altered biofilm architecture of saliva and curette-collected plaque and community composition of saliva, tongue and curette-harvested plaque. CONCLUSIONS: Different intraoral inocula served as precursors of in vitro oral polymicrobial biofilms which can be influenced by shear. SIGNIFICANCE AND IMPACT OF THE STUDY: Inoculum selection and shear force are key factors to consider when developing multispecies biofilms within in vitro models.


Asunto(s)
Biopelículas/crecimiento & desarrollo , Placa Dental/microbiología , Boca/microbiología , Saliva/microbiología , Lengua/microbiología , Bacterias/crecimiento & desarrollo , Bacterias/ultraestructura , Fenómenos Biomecánicos , Humanos , Microscopía Confocal , Resistencia al Corte
3.
Diabetes Obes Metab ; 18(2): 191-5, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26434934

RESUMEN

Phase I studies have shown that AMG 151 activates glucokinase, a key enzyme in glucose homeostasis. The present randomized, placebo-controlled phase IIa study evaluated the dose-effect relationship of the glucokinase activator AMG 151 relative to placebo on fasting plasma glucose (FPG) in 236 patients (33-35 patients per arm) with type 2 diabetes treated with metformin. Patients received oral AMG 151 at 50, 100 or 200 mg twice daily, AMG 151 at 100, 200 or 400 mg once daily or matching placebo for 28 days. A significant linear dose-effect trend was observed with the twice-daily regimen (p = 0.004) for change in FPG to day 28. No trend was observed with the once-daily regimen. A higher incidence of hypoglycaemia and hypertriglyceridaemia was observed with AMG 151 administration. AMG 151 significantly reduced FPG when administered twice daily but not when administered once daily in patients with type 2 diabetes treated with metformin.


Asunto(s)
Aminopiridinas/administración & dosificación , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Drogas en Investigación/administración & dosificación , Activadores de Enzimas/administración & dosificación , Glucoquinasa/metabolismo , Hiperglucemia/prevención & control , Hipoglucemia/prevención & control , Hipoglucemiantes/administración & dosificación , Tiadiazoles/administración & dosificación , Adulto , Aminopiridinas/efectos adversos , Aminopiridinas/uso terapéutico , Glucemia/análisis , Diabetes Mellitus Tipo 2/sangre , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Esquema de Medicación , Drogas en Investigación/efectos adversos , Drogas en Investigación/uso terapéutico , Activadores de Enzimas/efectos adversos , Activadores de Enzimas/uso terapéutico , Estudios de Seguimiento , Glucoquinasa/química , Hemoglobina Glucada/análisis , Cefalea/inducido químicamente , Cefalea/epidemiología , Humanos , Hiperglucemia/epidemiología , Hipertrigliceridemia/inducido químicamente , Hipertrigliceridemia/epidemiología , Hipoglucemia/inducido químicamente , Hipoglucemia/epidemiología , Hipoglucemiantes/efectos adversos , Hipoglucemiantes/uso terapéutico , Incidencia , Análisis de los Mínimos Cuadrados , Periodo Posprandial , Tiadiazoles/efectos adversos , Tiadiazoles/uso terapéutico , Triglicéridos/sangre
5.
Foot Ankle Surg ; 20(1): 40-3, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24480498

RESUMEN

BACKGROUND: Timing of surgery for ankle fractures is largely dependent on the condition of the surrounding soft-tissues. This study aimed to determine the clinical effectiveness of a pre-operative in-cast artero-venous (AV) impulse device in the management of closed ankle fractures requiring surgery. METHODS: A consecutive series of 64 closed ankle fractures were managed using the AV impulse system prior to surgery. Patients were compared to 73 consecutive closed ankle fractures managed surgically in the same unit immediately prior to the implementation of the AV impulse device study. Outcomes measured were time to surgery, length of hospital stay and surgical site infections. RESULTS: Median length of time to surgery, hospital stay duration and surgical site infections were all significantly reduced in the study group as compared to the control group. CONCLUSIONS: In-cast intermittent AV compression foot pumps in the pre-operative management of closed ankle fractures were associated with earlier surgery, earlier discharge and reduced complications.


Asunto(s)
Fracturas de Tobillo , Fracturas Óseas/terapia , Aparatos de Compresión Neumática Intermitente , Adulto , Moldes Quirúrgicos , Auditoría Clínica , Costos y Análisis de Costo , Femenino , Fracturas Óseas/economía , Humanos , Aparatos de Compresión Neumática Intermitente/economía , Tiempo de Internación , Masculino , Cuidados Preoperatorios , Estudios Retrospectivos , Infección de la Herida Quirúrgica/prevención & control
6.
Br J Cancer ; 106(11): 1779-89, 2012 May 22.
Artículo en Inglés | MEDLINE | ID: mdl-22549178

RESUMEN

BACKGROUND: Trastuzumab and pertuzumab target the Human Epidermal growth factor Receptor 2 (HER2). Combination therapy has been shown to provide enhanced antitumour activity; however, the downstream signalling to explain how these drugs mediate their response is not clearly understood. METHODS: Transcriptome profiling was performed after 4 days of trastuzumab, pertuzumab and combination treatment in human ovarian cancer in vivo. Signalling pathways identified were validated and investigated in primary ovarian xenografts at the protein level and across a timeseries. RESULTS: A greater number and variety of genes were differentially expressed by the combination of antibody therapies compared with either treatment alone. Protein levels of cyclin-dependent kinase inhibitors p21 and p27 were increased in response to both agents and further by the combination; pERK signalling was inhibited by all treatments; but only pertuzumab inhibited pAkt signalling. The expression of proliferation, apoptosis, cell division and cell-cycle markers was distinct in a panel of primary ovarian cancer xenografts, suggesting the heterogeneity of response in ovarian cancer and a need to establish predictive biomarkers. CONCLUSION: This first comprehensive study of the molecular response to trastuzumab, pertuzumab and combined therapy in vivo highlights both common and distinct downstream effects to agents used alone or in combination, suggesting that complementary pathways may be involved.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Expresión Génica/efectos de los fármacos , Neoplasias Ováricas/tratamiento farmacológico , Transducción de Señal/efectos de los fármacos , Animales , Anticuerpos Monoclonales Humanizados/administración & dosificación , Western Blotting , Femenino , Perfilación de la Expresión Génica , Humanos , Ratones , Ratones Desnudos , Análisis de Secuencia por Matrices de Oligonucleótidos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Trastuzumab , Ensayos Antitumor por Modelo de Xenoinjerto
7.
Caries Res ; 46(6): 513-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22813956

RESUMEN

This was a single-center, prospective, cross-sectional study stratified by age and gender with the objective of determining the relationship between gum chewing history, salivary flow, and dental caries severity in adults. We enrolled 191 subjects aged 18-65 years who underwent assessments for gum chewing history, unstimulated salivary flow rate, salivary pH, and caries severity. Unstimulated salivary flow rate tended to decline with increasing age (p = 0.04), and significant differences in unstimulated salivary flow rate were also found for males (0.58 ± 0.32 ml/min) versus females (0.48 ± 0.30 ml/min) (p = 0.02). Weekly gum chewing frequency was greater in younger subjects (p = 0.001) while no age group differences were noted in pieces per day or chewing duration. Gum chewing habits were similar in males and females. A multivariate model demonstrated that only days per week chewing gum (p < 0.001) and gender (p = 0.007) were predictive of unstimulated salivary flow rate (R(2) = 0.40). Mean caries severity scores, assessed via ICDAS II and DMFT, increased with age. In multivariate analysis, age was positively associated with ICDAS (p = 0.001) and days per week chewing gum was negatively associated with ICDAS (p = 0.004), indicating that caries severity increased with age, and that days of chewing provided an inverse effect, with increased days of chewing being associated with decreased severity of caries. Overall, a history of frequent gum chewing is associated with higher unstimulated salivary flow rate and lower caries severity.


Asunto(s)
Goma de Mascar/estadística & datos numéricos , Caries Dental/prevención & control , Saliva/metabolismo , Adolescente , Adulto , Anciano , Análisis de Varianza , China , Estudios Transversales , Índice CPO , Caries Dental/patología , Femenino , Humanos , Concentración de Iones de Hidrógeno , Masculino , Masticación , Persona de Mediana Edad , Estudios Prospectivos , Análisis de Regresión , Saliva/química , Tasa de Secreción , Adulto Joven
8.
Adv Dent Res ; 24(2): 58-62, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22899681

RESUMEN

Most surrogate measures of caries were developed to test products containing fluoride, typically at relatively high and closely controlled oral concentrations. However, since the primary mechanism for the remineralization of early enamel caries lesions by chewing gum is through stimulation of saliva, delivering Ca and Pi to the demineralized enamel lesion, established methods may lack the sensitivity to detect the additional benefit of an active agent without the strong remineralizing potential of fluoride. Issues related to the release of active agents from the gum matrix, dilution in the saliva, and limited oral retention time, along with taste, safety, regulatory, and cost concerns, impose further limitations. This paper reviews the efficacy of some active agents used in chewing gum for improved remineralization and includes results from in situ testing of calcium-containing gums, including calcium lactate, tetracalcium phosphate/dicalcium phosphate anhydrous, calcium citrate/encapsulated phosphate, and a calcium lactate/sodium phosphate blend. Despite promising in vitro data from these agents, they did not provide consistently superior results from in situ testing. There is a need to develop better predictive in vitro models for chewing gum, as well as improved sensitivity of in situ models to discriminate relatively small amounts of remineralization against a background of high biological variability.


Asunto(s)
Fosfatos de Calcio/uso terapéutico , Goma de Mascar , Caries Dental/prevención & control , Placa Dental/fisiopatología , Sistemas de Liberación de Medicamentos/métodos , Remineralización Dental/métodos , Análisis de Varianza , Esmalte Dental , Humanos , Saliva/fisiología , Xilitol/uso terapéutico
9.
Aust Vet J ; 100(1-2): 29-39, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-34651306

RESUMEN

Breed structures of Australian dairy herds over time were described for a large subset of milk-recording herds. The focus for this study was to describe the use of crossbreeding by dairy farmers, specifically proportions of herds using crossbreeding, whether they were using two-breed or three-breed crossbreeding systems, and how herd-breed structures changed over time. The most common breed structure in Australian milk-recording herds between 2000 and 2013 was two-breed crossbreeding (39% of herd-years). The next most common breed structure was purebred (35%). Over the period studied, the proportion of herds that were purebred decreased, while the proportion of herds that were crossbreeding increased (particularly three-breed crossbreeding herds). Herd-breed structures and changes over time varied with region and with the herd's calving system. There were also considerable changes in breed structure within herds, including herds changing breed structure before reverting back to their original breed structure. These results indicate that breed structures in milk-recording dairy herds in Australia are dynamic, and that farmers have commonly employed crossbreeding strategies.


Asunto(s)
Cruzamiento , Bovinos , Industria Lechera , Lactancia , Animales , Australia , Femenino , Hibridación Genética , Leche
10.
Osteoporos Int ; 20(12): 2105-10, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19337676

RESUMEN

SUMMARY: There are no previously published data for hip fracture incidence rates in the Republic of Ireland. The rates of fracture for the total population aged 50 years and over were 407 and 140 per 100,000 for females and males, respectively. Assuming a stable incidence rate, the absolute number of hip fractures occurring on an annual basis is expected to increase by 100% by the year 2026. Health care providers should accommodate these increases into future strategies. INTRODUCTION: Hip fractures are an important cause of morbidity in the elderly and represent an increasing burden on health service providers. Significant regional and international variation in incidence rates of hip fracture exists. In order for health service providers to be able to commit adequate resources to the care of hip fracture patients, accurate estimates of hip fracture numbers are required now and for the future. To date, there have been no reported incidence rates for hip fracture in the Republic of Ireland. METHODS: We performed a search of the national hospital in-patient enquiry database for all hip fractures occurring in the Republic of Ireland between 2000 and 2004. Population data was obtained from the 2002 national census data. Population projections were made for the years 2016 and 2026 to allow determination of expected hip fracture numbers for those years. RESULTS: The rates of hip fracture in the Irish population aged 50 years and over were 407 and 140 per 100,000 for females and males, respectively. Annual hip fracture numbers are expected to increase by 100% by the year 2026, assuming a stable incidence rate. CONCLUSION: Health service providers should take into account the expected increase in hip fracture numbers when allocating resources for the care of these patients in the mid-term future.


Asunto(s)
Fracturas de Cadera/epidemiología , Distribución por Edad , Anciano , Anciano de 80 o más Años , Asia/epidemiología , Métodos Epidemiológicos , Europa (Continente)/epidemiología , Femenino , Predicción , Hospitalización/estadística & datos numéricos , Humanos , Irlanda/epidemiología , Masculino , Persona de Mediana Edad , Distribución por Sexo , Estados Unidos/epidemiología
11.
Ir Med J ; 102(8): 262, 264, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19873869

RESUMEN

Hip fractures are an important cause of morbidity in the elderly and represent a significant proportion of acute orthopaedic admissions. We reviewed a consecutive series of hip fractures presenting to our unit over five years, obtaining demographic and clinical data from patient's medical records. Patients who remained in-patient for greater than fourteen days were analyzed for reasons responsible. We reviewed 717 consecutive hip fractures. The average length of stay was 28 days. Forty-nine percent of patients stayed in hospital greater than 14 days. Reasons for prolonged stay included both medical and social reasons. Direct postoperative complications were rarely responsible for prolonged hospital stay. Hip fractures constitute a significant burden on acute trauma services. Further strategies are needed to address both medical and social reasons for prolonged stay in hospital following hip fracture, as is a prospective national hip fracture audit to quantify the burden on the Irish health service.


Asunto(s)
Fracturas de Cadera/complicaciones , Fracturas de Cadera/cirugía , Tiempo de Internación/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Femenino , Fracturas del Fémur/complicaciones , Fracturas del Fémur/cirugía , Fémur/lesiones , Fémur/cirugía , Humanos , Irlanda , Masculino , Periodo Posoperatorio , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento
13.
Ir Med J ; 102(7): 224-6, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19772006

RESUMEN

Hip fractures are an important cause of morbidity and mortality in the elderly and represent an increasing burden on health service providers. There is significant regional and international variation in the incidence rates of such injuries, depending on age, sex and ethnic variations in populations. To date, there are no reported incidence rates for hip fractures in Ireland. Over a five year period, 717 low energy hip fractures were treated in the orthopaedic trauma unit of the Mater Misericordiae hospital. For this population, the female to male ratio was 3.3:1 (549 females and 166 males), the gender specific incidences were 470 per 100,000 and 179 per 100,000 for females and males, respectively. The overall age standardized rate was 341 per 100,000. This study quantifies the burden of hip fracture on a local population. With this knowledge, health service providers should be able to allocate appropriate resources for these patients in terms of acute and step-down care facilities.


Asunto(s)
Fracturas de Cadera/epidemiología , Factores de Edad , Anciano , Anciano de 80 o más Años , Bases de Datos Factuales , Femenino , Humanos , Incidencia , Irlanda/epidemiología , Tiempo de Internación , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Factores Sexuales
14.
Biochem Pharmacol ; 71(4): 408-15, 2006 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-16360645

RESUMEN

Novel ruthenium(II) organo-metallic compounds are active in ovarian cancer models [Aird RE, Cummings J, Ritchie AA, Muir M, Morris RE, Chen H, et al. In vitro and in vivo activity and cross resistance profiles of novel ruthenium(II) organometallic arene complexes in human ovarian cancer. Br J Cancer 2002;86(10):1652-7]. [(eta6-C6H5C6H5)Ru(en)Cl]+ (as a PF6 salt, where en=ethylenediamine (RM175)) has been evaluated in a 13-cell line panel. Particular sensitivity (approximately 10-fold lower than mean IC50) was noted in breast cancer and non-small cell lung cancer cell lines. In addition, IC50 in the A549 was 2 microM and RM175 (25 mg kg-1, days 1 and 5, i.p.) caused a significant (p=0.004) growth delay in a xenograft model. HC11 [(eta6-tetrahydroanthracene)Ru(en)Cl]PF6 was more potent in the A549 cell line (IC50 0.5 microM). HC11 (25 mg kg-1, days 1, 8 and 15, i.p.) was also active in vivo. Following RM175 25 mg kg-1, days 1 and 5, and 15 mg kg-1, days 1-5, HC11 25 and 40 mg kg-1, day 1, elevated alanine transaminase levels were detected, suggesting hepatotoxicity. No changes were observed in kidney or haematological parameters. In liver sections, multi-focal hepatic necrosis was seen, becoming confluent at high doses of HC11. In vitro studies confirmed that HC11 was more toxic than RM175 to fresh human hepatocytes and equitoxic to mithramycin. Liver toxicity may be related to the arene ligand and modification may reduce the potential for hepatic toxicity, while maintaining the anti-tumour activity seen.


Asunto(s)
Antineoplásicos/farmacología , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Neoplasias Pulmonares/tratamiento farmacológico , Compuestos Organometálicos/farmacología , Compuestos de Rutenio/farmacología , Ensayos Antitumor por Modelo de Xenoinjerto , Alanina Transaminasa/sangre , Animales , Antineoplásicos/química , Antineoplásicos/toxicidad , Carcinoma de Células Grandes/tratamiento farmacológico , Carcinoma de Células Grandes/patología , Carcinoma de Pulmón de Células no Pequeñas/patología , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Hepatocitos/citología , Hepatocitos/efectos de los fármacos , Humanos , Concentración 50 Inhibidora , Inyecciones Intraperitoneales , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/ultraestructura , Neoplasias Pulmonares/patología , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos , Ratones Desnudos , Compuestos Organometálicos/química , Compuestos Organometálicos/toxicidad , Compuestos de Rutenio/química , Compuestos de Rutenio/toxicidad , Pérdida de Peso/efectos de los fármacos
16.
Ir Med J ; 99(1): 13-4, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16506683

RESUMEN

Normal variations of lower limb development are a common source of parental concern and are commonly referred to paediatric orthopaedic clinics. To determine the proportion of children referred to a paediatric orthopaedic outpatients with potentially normal developmental variations, referral letters and case notes of children attending the paediatric orthopaedic clinic at our institution over three months were analysed and categorized according to the main reason for referral. The number with true orthopaedic pathology was documented. Variations of normal anatomy and physiology accounted for 53.1% of all new referrals seen at the clinic with intoeing and flexible flat feet being the commonest referrals in this category. The rate of true primary pathology was only 16.3%. Normal developmental variations form a significant proportion of all new referrals to paediatric orthopaedic clinics. These take time and resources to process. Strategies to minimise these referrals are needed.


Asunto(s)
Desarrollo Infantil/fisiología , Desarrollo Musculoesquelético/fisiología , Enfermedades Musculoesqueléticas/epidemiología , Niño , Preescolar , Humanos , Lactante , Irlanda/epidemiología , Valores de Referencia
17.
Eur J Cancer ; 34(3): 384-8, 1998 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9640227

RESUMEN

8-Chloroadenosine-3',5'-monophosphate (8-ClcAMP) is a novel antitumour agent currently undergoing phase I clinical trials in several European centres. In this study, its antitumour activity against human tumour xenografts and its dependence on schedule were investigated. When administered by continuous infusion at doses of 100 or 50 mg/kg/day to nude mice bearing human tumour xenografts, 8-ClcAMP inhibited the growth of the HT 29 colorectal, ZR-75-1 breast, HOX 60 and PE04 ovarian and PANC-1 pancreatic carcinoma xenografts. However, these infusion schedules produced hypercalcaemia and severe weight loss. In an attempt to optimise antitumour activity and minimise toxicity, several other schedules were studied. In comparison with continuous administration of 8-ClcAMP at 50 mg/kg/day for 14 days which, although producing complete growth inhibition in the HOX 60 model, was associated with a marked body weight loss, schedules in which the infusion was interrupted (infusion on either days 0-4; 7-11 or days 0-2; 6-8) produced minimal weight loss but also reduced antitumour activity. However, co-administration of salmon calcitonin with continuous infusion of 8-ClcAMP prevented both hypercalcaemia and body weight loss in 3/6 animals while still producing marked inhibition of tumour growth. These data indicate that 8-ClcAMP has broad-spectrum antitumour activity and the major side-effect of hypercalcaemia may at least in part be ameliorated by the use of salmon calcitonin.


Asunto(s)
8-Bromo Monofosfato de Adenosina Cíclica/análogos & derivados , Antineoplásicos/administración & dosificación , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Ováricas/tratamiento farmacológico , Neoplasias de la Próstata/tratamiento farmacológico , 8-Bromo Monofosfato de Adenosina Cíclica/administración & dosificación , Animales , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Humanos , Hipercalcemia/inducido químicamente , Infusiones Intravenosas , Masculino , Ratones , Trasplante de Neoplasias , Trasplante Heterólogo , Pérdida de Peso
18.
Pediatrics ; 68(6): 828-33, 1981 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7322719

RESUMEN

In an attempt to investigate the relationship of iron deficiency and mental status, cognitive development and attending behavior were assessed in nonanemic children aged 11 to 13 months who were severely or mildly iron deficient or were iron replete. Using two different approaches to the assessment of cognitive development and an habituation measure as an index of attending behavior, no statistically significant differences could be demonstrated in the overall level of performance between the iron-depleted and the iron-replete children. Isolated differences were demonstrated on a scale that measured fearfulness and on several of the scales that measured sensory areas of interest displayed.


Asunto(s)
Conducta Infantil , Cognición , Deficiencias de Hierro , Desarrollo Infantil , Femenino , Ferritinas/sangre , Habituación Psicofisiológica , Hematócrito , Humanos , Lactante , Masculino
19.
Br J Pharmacol ; 40(2): 227-36, 1970 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-5492895

RESUMEN

1. Administration of frusemide or ethacrynic acid to cephaloridine-treated mice increased both the incidence and extent of proximal renal tubular necrosis compared with that obtained in cephaloridine-treated control mice.2. Administration of frusemide to cephaloridine-treated rats produced significant changes in urine output, electrolyte excretion and proteinuria, and plasma urea nitrogen and creatinine values were significantly increased compared with controls or rats that received frusemide or cephaloridine alone.3. Histological examination of the kidneys showed a higher incidence and greater extent of tubular necrosis in rats that received both frusemide and cephaloridine.4. It is suggested that this adverse drug interaction may have contributed to the deterioration in renal function observed in some patients treated with diuretics and cephaloridine concurrently.


Asunto(s)
Lesión Renal Aguda/inducido químicamente , Cefaloridina , Ácido Etacrínico , Furosemida , Lesión Renal Aguda/patología , Animales , Nitrógeno de la Urea Sanguínea , Creatinina/sangre , Sinergismo Farmacológico , Femenino , Riñón/patología , Túbulos Renales/efectos de los fármacos , Masculino , Ratones , Potasio/orina , Proteinuria , Ratas , Sodio/orina , Orina
20.
Br J Pharmacol ; 132(7): 1374-82, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11264229

RESUMEN

1. Tamoxifen and a group of structurally similar non-steroidal, triphenolic compounds inhibit the oestrogen receptor. In addition to this action, these anti-oestrogens are known to inhibit some types of plasma membrane ion channels and other proteins through mechanisms that do not appear to involve their interactions with the estrogen receptor but could be the result of their effect on membrane lipid structure or fluidity. 2. We studied the effects of beta-estradiol and three anti-oestrogens (tamoxifen, 4-hydroxytamoxifen and clomiphene) on Ca(2+) uptake into sarcoplasmic reticulum (SR) vesicles isolated from canine cardiac ventricular tissue. 3. The antiestrogens all inhibit SR Ca(2+) uptake in a concentration-dependent manner (order of potency: tamoxifen > 4-hydroxytamoxifen > or = clomiphene). Although these compounds rapidly inhibit net Ca(2+) uptake they do not have a similar rapid effect on the ATPase activity of the SR Ca pump. beta-estradiol has no effect on Ca(2+) uptake nor does it alter the inhibitory action of tamoxifen on the SR. 4. The differences in the effects of beta-estradiol and the anti-oestrogens on cardiac SR Ca(2+) uptake do not correlate with differences in the ways in which these compounds have been reported to interact with membrane lipids. Our results are consistent, however, with direct effects on a membrane protein (possibly an SR Cl(-) or K(+) channel).


Asunto(s)
Calcio/farmacocinética , Estradiol/farmacología , Antagonistas de Estrógenos/farmacología , Retículo Sarcoplasmático/efectos de los fármacos , Tamoxifeno/análogos & derivados , Tamoxifeno/farmacología , Adenosina Trifosfatasas/metabolismo , Animales , Calcio/metabolismo , Clomifeno/farmacología , Perros , Relación Dosis-Respuesta a Droga , Miocardio/metabolismo , Retículo Sarcoplasmático/metabolismo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda